Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

被引：1
|
作者：
Di, Mengyang [1 ,2 ]
Long, Jessica B. [1 ]
Kothari, Shalin K. [3 ]
Sethi, Tarsheen [3 ]
Zeidan, Amer M. [1 ,3 ]
Podoltsev, Nikolai A. [1 ,3 ]
Shallis, Rory Michael [1 ,3 ]
Wang, Rong [1 ,4 ]
Stempel, Jessica M. [2 ]
Ma, Xiaomei [1 ,4 ]
Huntington, Scott F. [1 ,3 ]
机构：
[1] Yale Univ, Sch Med, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
[2] Yale Univ, Dept Internal Med, Hematol Oncol, Sch Med, New Haven, CT USA
[3] Yale Univ, Dept Internal Med, Sect Hematol, Sch Med, New Haven, CT USA
[4] Yale Univ, Dept Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10904 / 10906
页数：3
相关论文
共 50 条
  • [1] Real-world (RW) treatment patterns and comparative effectiveness of Bruton tyrosine kinase inhibitors (BTKi) in patients (pts) with mantle cell lymphoma (MCL).
    Shah, Bijal D.
    Yang, Keri
    Klink, Andrew J.
    Liu, Tom
    Zimmerman, Todd M.
    Gajra, Ajeet
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18727 - E18727
  • [2] Real-world treatment patterns of bruton tyrosine kinase inhibitors (BTKi) in patients with mantle cell lymphoma (MCL) in community oncology practices in the United States (US)
    Shah, Bijal D.
    Xue, Mei
    Yang, Keri
    Liu, Sizhu
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Real-world adherence and healthcare resource utilization of Bruton tyrosine kinase inhibitors (BTKi) in mantle cell lymphoma.
    Shah, Bijal D.
    Furnback, Wesley
    Esselman, Kaitlyn
    Chuang, Po-Ya
    Xue, Mei
    Yang, Keri
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
    Di, Mengyang
    Cui, Can
    Kothari, Shalin K.
    Zeidan, Amer M.
    Podoltsev, Nikolai A.
    Neparidze, Natalia
    Shallis, Rory M.
    Wang, Rong
    Ma, Xiaomei
    Huntington, Scott F.
    BLOOD ADVANCES, 2022, 6 (11) : 3339 - 3342
  • [5] Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based Analysis
    Di, Mengyang
    Cui, Can
    Kothari, Shalin K.
    Zeidan, Amer M.
    Podoltsev, Nikolai
    Neparidze, Natalia
    Shallis, Rory M.
    Wang, Rong
    Ma, Xiaomei
    Huntington, Scott F.
    BLOOD, 2021, 138
  • [6] EFFICACY OUTCOMES FOLLOWING TREATMENT WITH BRUTON TYROSINE KINASE INHIBITORS (BTKI) FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (R/R MCL): A LITERATURE-BASED META-ANALYSIS
    Dreyling, M.
    Shah, B.
    Wu, J. J.
    Chen, J.
    Keeping, S.
    Chan, K.
    Wade, S.
    Peng, W.
    Kloos, I
    Wang, M.
    VALUE IN HEALTH, 2022, 25 (07) : S609 - S610
  • [7] Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis
    Di, Mengyang
    Long, Jessica B.
    Kothari, Shalin K.
    Sethi, Tarsheen
    Zeidan, Amer M.
    Podoltsev, Nikolai A.
    Shallis, Rory M.
    Wang, Rong
    Ma, Xiaome
    Huntington, Scott F.
    HAEMATOLOGICA, 2023, 108 (08) : 2218 - 2223
  • [8] Real-World Characteristics and Survival Outcomes of Patients with Mantle Cell Lymphoma Treated with Covalent Bruton's Tyrosine Kinase Inhibitors in First-Line
    Sawas, Ahmed
    Wade, Niquelle Brown
    Roose, James
    BLOOD, 2024, 144 : 1655 - 1656
  • [9] Real-World (RW) Comparative Effectiveness of Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) Among Patients With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)
    Phillips, Tycel
    Guinter, Mark A.
    Miller, Taavy A.
    Wang, Jingru
    Pierre, Amy
    Maglinte, Gregory A.
    Seymour, Erlene K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S517 - S517
  • [10] Real-World Bruton Tyrosine Kinase Inhibitor Treatment Patterns, Compliance, Costs, and Hospitalizations in Patients with Mantle Cell Lymphoma in the United States
    Shah, Bijal D.
    Yang, Keri
    Liu, Sizhu
    Sivanantham, Jai
    Ali, Yasser
    Casten, Chris
    Satya, Swaroop
    Tang, Boxiong
    BLOOD, 2021, 138
12345